Cover Image

Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study

Abstract Background This study analyzed the changes of serum and pathological biomarkers during fertility-sparing therapy of endometrial cancer (EC) or endometrial atypical hyperplasia (EAH), to investigate their implications for early prediction of treatment efficacy. Methods A retrospective analys...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yiqin Wang (Author), Rong Zhou (Author), Xiaobo Zhang (Author), Huixin Liu (Author), Danhua Shen (Author), Jianliu Wang (Author)
Format:	Book
Published:	BMC, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characteristics of molecular classification in 52 endometrial cancer and atypical hyperplasia patients receiving fertility-sparing treatment
by: Yiqin Wang, et al.
Published: (2023)

Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
by: Yuan Fan, et al.
Published: (2021)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
by: Yingqiao Ding, et al.
Published: (2022)

Clinical features and outcome of 15 patients with recurrent endometrial cancer or atypical endometrial hyperplasia received primary fertility-sparing therapy followed by hysterectomy
by: Yuanting Li, et al.
Published: (2021)

Pregnancy outcomes after fertility preservation in women with endometrial carcinoma and atypical endometrial hyperplasia: A systematic review and meta-analysis
by: Zerui Xiao, et al.
Published: (2021)

Reproductive advance of fertility preservation in patients with early endometrial carcinoma or endometrial atypical hyperplasia
by: Jiao Yu, et al.
Published: (2022)

Chinese expert consensus on fertility-preserving treatment for young women with early stage well differentiated endometrial cancer
by: Rong Zhou, et al.
Published: (2021)

Fertility-Sparing Treatment in Endometrial Cancer
by: Yenrudee Poomtavorn
Published: (2019)

New insights into fertility-sparing treatment of endometrial cancer
by: Luca Giannella, et al.
Published: (2024)

Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol
by: Xin Zhao, et al.
Published: (2022)

Results of surgical treatment of atypical endometrial hyperplasia
by: O. A. Gornykh, et al.
Published: (2014)

Recurrent endometrial atypical hyperplasia diagnosed by pathological examination of the placenta from a live birth: a case report
by: Weilu Wu, et al.
Published: (2023)

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
by: Haley A. Moss, et al.
Published: (2014)

Laparoscopic surgery for atypical endometrial hyperplasia with awareness regarding the possibility of endometrial cancer
by: Misato Kamii, et al.
Published: (2023)

Fertility-sparing treatment of endometrial cancer - is it possible? A case study
by: Milena Leziak, et al.
Published: (2022)

Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
by: Xinxin Zhu, et al.
Published: (2023)

Diagnostic accuracy of hysteroscopic scoring system in predicting endometrial malignancy and atypical endometrial hyperplasia
by: Bhukya Harika, et al.
Published: (2021)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
by: А. E. Protasova, et al.
Published: (2024)

Value of endometrial thickness for the detection of endometrial cancer and atypical hyperplasia in asymptomatic postmenopausal women
by: Linna Zhang, et al.
Published: (2022)

Fertility-sparing treatment in early endometrial cancer: current state and future strategies
by: Andreas Obermair, et al.
Published: (2020)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
by: A.M. Newtson, et al.
Published: (2017)

The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study
by: Lana G. Dzhanashvili, et al.
Published: (2022)

Fertility-Sparing Management of Early Stage Endometrial Cancer: A Narrative Review of the Literature
by: Alison Montgomery, et al.
Published: (2023)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
by: Lee Shi Hui, et al.
Published: (2021)

Expression of pinopodies in women with endometry hyperplasia without atipy and fertility disorders
by: E. N. Nosenko, et al.
Published: (2017)

Expression of pinopodies in women with endometry hyperplasia without atipy and fertility disorders
by: E. N. Nosenko, et al.
Published: (2017)

Risk of endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia treated with total laparoscopic hysterectomy
by: Katsutoshi Oda, et al.
Published: (2016)

Comparatively analyzed quality of life in patients with atypical endometrial hyperplasia and endometrial cancer during various rehabilitation activities
by: L. N. Sandzhieva, et al.
Published: (2022)

Effectiveness of megestrol for the treatment of patients with atypical endometrial hyperplasia or endometrial endometrioid adenocarcinoma (Stage IA, well differentiated)
by: Setareh Akhavan, et al.
Published: (2021)

The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary
by: Qujia Gama, et al.
Published: (2023)

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia
by: Steven Wang, MD, et al.
Published: (2015)

Fertility-sparing in cancer patients
by: Sema Karakaş, et al.
Published: (2021)

Rationality of the FIGO2023 staging for early-stage endometrial cancer, compared with the FIGO2009 staging
by: Yiqin Wang, et al.
Published: (2024)

Restoration of endometrial receptivity and reproductive function in infertile women with excess body weightand complex non-atypical endometrial hyperplasia
by: O. Nosenko, et al.
Published: (2022)

Atypical hyperplasias of the breast
by: I. V. Vysotskaya, et al.
Published: (2015)

Analysis of the objective and preventative treatment and efficacy of therapeutic approaches in women with non-atypical endometrial hyperplasia
by: O. L. Gromova
Published: (2020)

Surgical Treatment of Endometrial Cancer and Atypical Hyperplasia: A Trend Shift from Laparotomy to Laparoscopy
by: Erik Qvigstad, et al.
Published: (2011)

Risk factors for atypical hyperplasia and endometrial cancer in the infertility population: a case-control study
by: Jenna L. Kahn, M.D, et al.
Published: (2021)

Possibilities of preserving reproductive function in female patients with atypical hyperplasia and endometrial cancer at an early stage
by: O.F. Serova, et al.
Published: (2023)

Histological component quantification for the evaluation of endometrial receptivity in women with natural cycles undergoing in vitro fertilization/intracytoplasmic sperm injection
by: Dong-Ying Wang, et al.
Published: (2017)